4554 Stock Overview
Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Fuji Pharma Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,599.00 |
| 52 Week High | JP¥2,060.00 |
| 52 Week Low | JP¥1,089.00 |
| Beta | 0.24 |
| 1 Month Change | -0.93% |
| 3 Month Change | 23.09% |
| 1 Year Change | -8.05% |
| 3 Year Change | 55.70% |
| 5 Year Change | 22.72% |
| Change since IPO | 106.32% |
Recent News & Updates
Fuji Pharma Co., Ltd. (TSE:4554) Held Back By Insufficient Growth Even After Shares Climb 27%
Dec 02
Impressive Earnings May Not Tell The Whole Story For Fuji Pharma (TSE:4554)
Nov 20Recent updates
Fuji Pharma Co., Ltd. (TSE:4554) Held Back By Insufficient Growth Even After Shares Climb 27%
Dec 02Impressive Earnings May Not Tell The Whole Story For Fuji Pharma (TSE:4554)
Nov 20Lacklustre Performance Is Driving Fuji Pharma Co., Ltd.'s (TSE:4554) 27% Price Drop
Aug 05Fuji Pharma's (TSE:4554) Shareholders Will Receive A Bigger Dividend Than Last Year
Jul 22Fuji Pharma (TSE:4554) Is Increasing Its Dividend To ¥22.50
Jul 03Fuji Pharma (TSE:4554) Has Announced That It Will Be Increasing Its Dividend To ¥22.50
Jun 19Impressive Earnings May Not Tell The Whole Story For Fuji Pharma (TSE:4554)
May 21Fuji Pharma (TSE:4554) Will Pay A Larger Dividend Than Last Year At ¥22.50
May 13Fuji Pharma's (TSE:4554) Dividend Will Be ¥20.00
Feb 28Shareholder Returns
| 4554 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | 2.6% | 0.9% | 2.1% |
| 1Y | -8.1% | 11.8% | 15.6% |
Return vs Industry: 4554 underperformed the JP Pharmaceuticals industry which returned 12.8% over the past year.
Return vs Market: 4554 underperformed the JP Market which returned 16.3% over the past year.
Price Volatility
| 4554 volatility | |
|---|---|
| 4554 Average Weekly Movement | 3.8% |
| Pharmaceuticals Industry Average Movement | 3.8% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in JP Market | 7.2% |
| 10% least volatile stocks in JP Market | 1.8% |
Stable Share Price: 4554 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4554's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1965 | 1,658 | Shuhei Morita | www.fujipharma.jp |
Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women, in vitro diagnostics, acute medical care products, and curative medicines, as well as information regarding pharmaceuticals and health; and contract manufacturing services.
Fuji Pharma Co., Ltd. Fundamentals Summary
| 4554 fundamental statistics | |
|---|---|
| Market cap | JP¥38.88b |
| Earnings (TTM) | JP¥6.15b |
| Revenue (TTM) | JP¥46.14b |
6.3x
P/E Ratio0.8x
P/S RatioIs 4554 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4554 income statement (TTM) | |
|---|---|
| Revenue | JP¥46.14b |
| Cost of Revenue | JP¥28.29b |
| Gross Profit | JP¥17.84b |
| Other Expenses | JP¥11.70b |
| Earnings | JP¥6.15b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 252.79 |
| Gross Margin | 38.68% |
| Net Profit Margin | 13.32% |
| Debt/Equity Ratio | 52.6% |
How did 4554 perform over the long term?
See historical performance and comparisonDividends
2.8%
Current Dividend Yield15%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 06:01 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Fuji Pharma Co., Ltd. is covered by 7 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yoshinaga Toshiaki | Aizawa Securities Co. Ltd. |
| Masao Yoshida | Ichiyoshi Research Institute Inc. |
| Shigekazu Ishida | Marusan Securities Co. Ltd. |